Peter H. Gann

13.8k total citations · 3 hit papers
163 papers, 9.3k citations indexed

About

Peter H. Gann is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Peter H. Gann has authored 163 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 46 papers in Molecular Biology and 41 papers in Cancer Research. Recurrent topics in Peter H. Gann's work include Prostate Cancer Treatment and Research (39 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Cancer Risks and Factors (17 papers). Peter H. Gann is often cited by papers focused on Prostate Cancer Treatment and Research (39 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Cancer Risks and Factors (17 papers). Peter H. Gann collaborates with scholars based in United States, India and Canada. Peter H. Gann's co-authors include Charles H. Hennekens, Edward L. Giovannucci, Meir J. Stampfer, June M. Chan, Jing Ma, Michaël Pollak, Peter Wilkinson, Susan M. Gapstur, Frank M. Sacks and Laura A. Colangelo and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Peter H. Gann

160 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

1998 1.6k citations Peter H. Gann et al. profile →
A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer

1995 554 citations Peter H. Gann profile →
Prostate Specific Antigen Best Practice Statement: 2009 Update

2009 390 citations Peter H. Gann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter H. Gann United States	45	2.7k	2.4k	2.0k	2.0k	1.8k	163	9.3k
June M. Chan United States	53	3.3k 1.2×	3.3k 1.3×	3.3k 1.6×	3.2k 1.6×	2.2k 1.2×	203	13.1k
Laurel A. Habel United States	47	1.8k 0.7×	3.2k 1.3×	3.7k 1.8×	1.4k 0.7×	2.6k 1.5×	200	9.9k
Paola Muti United States	64	1.3k 0.5×	3.9k 1.6×	3.4k 1.7×	1.5k 0.7×	2.4k 1.3×	253	12.2k
George G. Klee United States	57	3.0k 1.1×	2.8k 1.1×	1.7k 0.8×	2.9k 1.4×	1.0k 0.6×	245	11.6k
Phyllis J. Goodman United States	45	6.8k 2.6×	2.3k 0.9×	3.5k 1.7×	1.7k 0.9×	1.9k 1.1×	160	13.2k
R K Ross United States	54	1.8k 0.7×	3.1k 1.2×	3.2k 1.6×	1.5k 0.8×	2.0k 1.1×	77	10.9k
Herbert Yu United States	62	1.4k 0.5×	6.0k 2.4×	3.6k 1.8×	2.1k 1.0×	3.6k 2.0×	254	12.1k
Christopher A. Haiman United States	48	1.6k 0.6×	2.9k 1.2×	2.1k 1.1×	833 0.4×	1.4k 0.8×	264	8.8k
William J. Aronson United States	61	6.3k 2.4×	1.8k 0.7×	2.5k 1.2×	1.5k 0.8×	2.3k 1.3×	310	12.1k
Ann W. Hsing United States	67	4.8k 1.8×	3.5k 1.4×	3.6k 1.8×	2.0k 1.0×	2.3k 1.3×	254	14.8k

Countries citing papers authored by Peter H. Gann

Since Specialization

Citations

This map shows the geographic impact of Peter H. Gann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Gann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Gann more than expected).

Fields of papers citing papers by Peter H. Gann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Gann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Gann. The network helps show where Peter H. Gann may publish in the future.

Co-authorship network of co-authors of Peter H. Gann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Gann. A scholar is included among the top collaborators of Peter H. Gann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Gann. Peter H. Gann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gann, Peter H., et al.. (2024). Deep Learning Predicts Subtype Heterogeneity and Outcomes in Luminal A Breast Cancer Using Routinely Stained Whole-Slide Images. Cancer Research Communications. 5(1). 157–166. 2 indexed citations

Kumar, Neeraj, Peter H. Gann, Stephanie M. McGregor, & Amit Sethi. (2023). Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival. Breast Cancer Research and Treatment. 200(2). 225–235. 6 indexed citations

Vigneswaran, Hari T., et al.. (2023). Biparametric Quantitative MRI for Prostate Cancer Detection. Topics in Magnetic Resonance Imaging. 32(6). 66–72. 2 indexed citations

Leonardo, Trevor R., Michael J. Schlicht, Klara Valyi‐Nagy, et al.. (2023). Prostate‐derived circulating microRNAs add prognostic value to prostate cancer risk calculators. SHILAP Revista de lepidopterología. 2(11). 1 indexed citations

Gao, Xin, Chenguang Wang, Peter H. Gann, et al.. (2022). Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas. Cancer Research Communications. 2(12). 1727–1737. 5 indexed citations

Gao, Xin, Chenguang Wang, Carlos Murga‐Zamalloa, et al.. (2022). Notch Signaling Promotes Mature T-Cell Lymphomagenesis. Cancer Research. 82(20). 3763–3773. 6 indexed citations

Hollowell, Courtney M.P., Ximing J. Yang, Marin Sekosan, et al.. (2021). Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer. SHILAP Revista de lepidopterología. 2(6). 370–376. 7 indexed citations

Al‐Alem, Umaima, Abeer M. Mahmoud, Ken Batai, et al.. (2021). Genetic Variation and Immunohistochemical Localization of the Glucocorticoid Receptor in Breast Cancer Cases from the Breast Cancer Care in Chicago Cohort. Cancers. 13(10). 2261–2261. 5 indexed citations

Kumar, Neeraj, Dan Zhao, Dulal K. Bhaumik, Amit Sethi, & Peter H. Gann. (2019). Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes. BMC Cancer. 19(1). 215–215. 10 indexed citations

10.

Acosta, Andrés, Ryan Deaton, Adam B. Murphy, et al.. (2019). Association of High miR-182 Levels with Low-Risk Prostate Cancer. American Journal Of Pathology. 189(4). 911–923. 14 indexed citations

11.

Qiao, Guilin, Jian‐Zhong Qin, Dolores Mahmud, et al.. (2017). LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. Cancer Research. 77(8). 1880–1891. 34 indexed citations

12.

Preston, Mark A., Julie L. Batista, Kathryn M. Wilson, et al.. (2016). Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. Journal of Clinical Oncology. 34(23). 2705–2711. 77 indexed citations

13.

Sethi, Amit, Abhishek Vahadane, Ryan Deaton, et al.. (2016). Empirical comparison of color normalization methods for epithelial-stromal classification in H and E images. Journal of Pathology Informatics. 7(1). 17–17. 38 indexed citations

14.

Verma, Ruchika, Neeraj Kumar, Amit Sethi, & Peter H. Gann. (2016). Detecting multiple sub-types of breast cancer in a single patient. 2648–2652. 7 indexed citations

15.

Moreno‐Vinasco, Liliana, Hector Quijada, Saad Sammani, et al.. (2014). Nicotinamide Phosphoribosyltransferase Inhibitor Is a Novel Therapeutic Candidate in Murine Models of Inflammatory Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 51(2). 223–228. 39 indexed citations

16.

Gann, Peter H., Larisa Nonn, Craig A. Beam, et al.. (2010). Gene Expression Patterns in the Human Breast after Pregnancy. Cancer Prevention Research. 3(3). 301–311. 99 indexed citations

17.

Gapstur, Susan M., Peter H. Gann, Peter Kopp, et al.. (2002). Serum Androgen Concentrations in Young Men: A Longitudinal Analysis of Associations with Age, Obesity, and Race.. Cancer Epidemiology and Prevention Biomarkers. 11(10). 1041–1047. 82 indexed citations

18.

Gann, Peter H., et al.. (1994). Does maternal prenatal care use predict infant immunization delay?. PubMed. 26(3). 172–8. 21 indexed citations

19.

Melville, Sharon, et al.. (1993). Office systems for promoting screening mammography. A survey of primary care practices.. PubMed. 37(6). 569–74. 10 indexed citations

20.

Bernstein, Inge, et al.. (1985). The diversity of reaginic immune responses to platinum and palladium metallic salts. Journal of Allergy and Clinical Immunology. 76(6). 794–802. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact